Insider trades
Stephen Davis, CEO of Acadia Pharmaceuticals ACAD, has filed 0 purchases and 15 sales on the open market. The latest trade was on 24/08/19.
Stephen Davis
CEO
- Company
- Acadia Pharmaceuticals ACAD
- First filing
- 23/01/05
- Trades
- 44 trades
- Buys / sales
- 0 / 15
- 12-month net buying
- No record
- Last trade
- 24/08/19
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market sale | 24/08/19 | 24/08/20 | 31,747 sh | $15.28 | $485,094.16 | −14.5% | |
| Open-market sale | 24/05/02 | 24/05/03 | 11,427 sh | $16.94 | $193,573.38 | −6.9% | |
ACAD | Open-market sale | 24/04/08 | 24/04/09 | 26,574 sh2 trades | $17.87avg. | $474,877.38 | −15.6% |
| Open-market sale | 24/03/27 | 24/03/27 | 17,714 sh | $17.90 | $317,080.6 | −13.0% | |
| Open-market sale | 24/02/26 | 24/02/27 | 5,577 sh | $24.67 | $137,584.59 | −5.2% | |
| Open-market sale | 24/01/08 | 24/01/09 | 3,732 sh | $29.96 | $111,810.72 | −3.7% | |
| Open-market sale | 23/10/06 | 23/10/06 | 51,563 sh | $21.96 | $1,132,323.48 | −36.6% | |
| Open-market sale10b5-1 plan | 23/07/14 | 23/07/18 | 100,000 sh | $30.04 | $3,004,000 | −73.2% | |
ACAD | Open-market sale10b5-1 plan | 23/07/11–23/07/12 | 23/07/13 | 71,602 sh2 trades | $25.04avg. | $1,792,805.2 | −66.1% |
| Open-market sale | 23/05/01 | 23/05/02 | 7,806 sh | $21.18 | $165,331.08 | −6.7% | |
| Open-market sale | 23/04/06 | 23/04/07 | 8,582 sh | $18.16 | $155,849.12 | −7.9% | |
| Open-market sale | 23/02/24 | 23/02/27 | 3,851 sh | $18.78 | $72,321.78 | −4.0% | |
| Open-market sale | 23/01/09 | 23/01/10 | 3,904 sh | $17.13 | $66,875.52 | −4.4% |